Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
BRC4wt is an acetylated peptide derived from the BRC4 repeat in human BRCA2 (1521-1536) and an... more
Product information "BRC4wt (trifluoroacetate salt)"
BRC4wt is an acetylated peptide derived from the BRC4 repeat in human BRCA2 (1521-1536) and an inhibitor of the protein-protein interaction between BRCA2 and RAD51. When coupled to the cationic cell-penetrating peptide (Arg)9 (Cay-36714), BRC4wt shortens DNA replication tract lengths and reduces homologous repair frequency of DNA damage induced by the DNA topoisomerase I inhibitor camptothecin (Cay-11694) in vitro, as well as potentiates cell death induced by the poly(ADP-ribose) polymerase (PARP) inhibitor olaparib (Cay-10621) in HeLa human cervical cancer and U2OS human osteosarcoma cells but not in non-cancerous hTERT RPE-1, MRC-5, or MCF-10A cells.Formal Name: (S)-2-((5S,8S,11S,14S,17S,23S,26S)-14-((1H-imidazol-5-yl)methyl)-17-benzyl-11-((R)-1-hydroxyethyl)-5-(hydroxymethyl)-23,26-diisobutyl-8-methyl-4,7,10,13,16,19,22,25,28-nonaoxo-3,6,9,12,15,18,21,24,27-nonaazanonacosanamido)-6-amino-N-((5S,8S,11S,14S,17S,20S)-1,24-diamino-14-(4-aminobutyl)-11-((S)-sec-butyl)-5-carbamoyl-17-isopropyl-8-methyl-7,10,13,16,19-pentaoxo-6,9,12,15,18-pentaazatetracosan-20-yl)hexanamide, trifluoroacetate salt. Molecular Formula: C81H139N23O19 . XCF3COOH. Formula Weight: 1739.1. Purity: >98%. Formulation: (Request formulation change), A solid. Peptide Sequence: Ac-LLGFHTASGKKVKIAK-NH2. Solubility: Water: Soluble. SMILES: NC([C@H](CCCCN)NC([C@@H](NC([C@@]([C@H](CC)C)([H])NC([C@H](CCCCN)NC([C@H](C(C)C)NC([C@H](CCCCN)NC([C@H](CCCCN)NC(CNC([C@H](CO)NC([C@@H](NC([C@@]([C@@H](C)O)([H])NC([C@@H](NC([C@@H](NC(CNC([C@H](CC(C)C)NC([C@H](CC(C)C)NC(C)=O)=O)=O)=O)CC1=CC=CC=C1)=O)CC2=CN=CN2)=O)=O)C)=O)=O)=O)=O)=O)=O)=O)=O)C)=O)=O.OC(C(F)(F)F)=O. InChi Code: InChI=1S/C81H139N23O19.C2HF3O2/c1-13-47(8)66(80(122)91-48(9)69(111)96-54(68(86)110)27-17-21-31-82)103-75(117)57(30-20-24-34-85)98-79(121)65(46(6)7)102-74(116)56(29-19-23-33-84)97-73(115)55(28-18-22-32-83)94-63(108)40-89-72(114)62(42-105)101-70(112)49(10)92-81(123)67(50(11)106)104-78(120)61(38-53-39-87-43-90-53)100-77(119)60(37-52-25-15-14-16-26-52)95-64(109)41-88-71(113)58(35-44(2)3)99-76(118)59(36-45(4)5)93-51(12)107,3-2(4,5)1(6)7/h14-16,25-26,39,43-50,54-62,65-67,105-106H,13,17-24,27-38,40-42,82-85H2,1-12H3,(H2,86,110)(H,87,90)(H,88,113)(H,89,114)(H,91,122)(H,92,123)(H,93,107)(H,94,108)(H,95,109)(H,96,111)(H,97,115)(H,98,121)(H,99,118)(H,100,119)(H,101,112)(H,102,116)(H,103,117)(H,104,120),(H,6,7)/t47-,48-,49-,50+,54-,55-,56-,57-,58-,59-,60-,61-,62-,65-,66-,67-,/m0./s1. InChi Key: OQBACIUJSFOCAS-QTTULFAFSA-N.
Keywords: | (S)-2-((5S,8S,11S,14S,17S,23S,26S)-14-((1H-imidazol-5-yl)methyl)-17-benzyl-11-((R)-1-hydroxyethyl)-5-(hydroxymethyl)-23,26-diisobutyl-8-methyl-4,7,10,13,16,19,22,25,28-nonaoxo-3,6,9,12,15,18,21,24,27-nonaazanonacosanamido)-6-amino-N-((5S,8S,11S,14S,17S,20 |
Supplier: | Cayman Chemical |
Supplier-Nr: | 38848 |
Properties
Application: | BRCA2-RAD51 protein-protein interaction inhibitor |
Conjugate: | No |
MW: | 1739.1 D |
Formula: | C81H139N23O19 . XCF3COOH |
Purity: | >98% |
Format: | Solid |
Database Information
KEGG ID : | K08775 | Matching products |
Handling & Safety
Storage: | -20°C |
Shipping: | +20°C (International: -20°C) |
Caution
Our products are for laboratory research use only: Not for administration to humans!
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow.
more
You will get a certificate here
Viewed